SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.06+2.6%3:22 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (7272)3/22/1999 8:32:00 PM
From: Anthony Wong  Read Replies (1) of 9523
 
03/22 19:46 Merck <MRK.N> launching pain drug Vioxx in Mexico

MEXICO CITY, March 22 (Reuters) - U.S. pharmaceutical giant Merck and
Co. Inc. said on Monday that Mexico would be the first market where its
new pain reliever Vioxx would be available with its launch here this week.

"Mexico will be the first country in the world to have Vioxx available," a
statement from the company's Merck Sharp and Dohme unit said. It said
Mexican health authorities approved the drug on Feb. 1.

Vioxx is one of a new line of pain relievers known as Cox-2 inhibitors
designed to treat pain and arthritis without the gastrointestinal side effects
often seen in aspirin and ibuprofen.

Brisk initial U.S. sales of G.D. Searle & Co's <MTC.N> Cox-2 inhibitor,
Celebrex, have put it on track to top Pfizer Inc. <PFE.N> impotency drug
Viagra as the most successful drug launch ever.

Vioxx is due to be reviewed by a U.S. Food and Drug Administration
advisory committee in April, with approval expected this spring.
Germany's Boehringer Ingelheim also has a Cox-2 drug expected to be
approved in the U.S. late this year.

moneynet.com@NEWS-P1&Index=0&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext